NASDAQ:AMGN
Amgen Inc. Stock News
$262.75
-1.32 (-0.500%)
At Close: Apr 18, 2024
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
07:06pm, Wednesday, 17'th Apr 2024
Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.
This biotech high-dividend stock is beating S&P 500
08:52am, Wednesday, 17'th Apr 2024
Dividend investing can be a profitable strategy for traders, providing an extra source of income alongside potential stock gains. Amgen (NASDAQ: AMGN) has demonstrated strong performance, surpassing t
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
07:30am, Wednesday, 17'th Apr 2024
Amgen, a leading U.S. biotech company, has outperformed the S&P 500 since 2011. However, the biotech's shares have struggled in 2024.
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
04:30am, Wednesday, 17'th Apr 2024
Delta Air Lines shares could finally take off this year once enough investors can shake off unmerited worries. Drugmaker Amgen's singles and doubles approach to the business makes more sense than alwa
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
07:09pm, Tuesday, 16'th Apr 2024
A couple of big-picture trends in biotech could add up to a nice investment opportunity. First, corporate buyouts are back in style.
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
05:26pm, Tuesday, 16'th Apr 2024
Planning Underway for Phase 3 Development of Tezepelumab in COPD THOUSAND OAKS, Calif. , April 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Pha
3 Stocks to Buy Low Today With High Hopes for Tomorrow
03:07pm, Monday, 15'th Apr 2024
Due to its obvious nature, one of the most commonly repeated pieces of advice regarding stock investment is to buy undervalued stocks when they trade low and sell overvalued stocks when they trade hig
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:10am, Monday, 15'th Apr 2024
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Amgen: I Prefer To Chase Value And Dividends
08:15am, Monday, 15'th Apr 2024
Amgen has a history of outperforming peers and the market due to its effective capital allocation in the pharmaceutical industry. AMGN is executing well with sales and volume growth, and has a robust
Amgen: The Giant With An Impressive Pipeline
04:25am, Monday, 15'th Apr 2024
Amgen's acquisition of Horizon Therapeutics has made it a major player in the rare disease space, with potential for long-term shareholder return. The company has key pipeline milestones in 2024, focu
Final Trades: Shell, 2-YR T-Note and Amgen
02:10pm, Friday, 12'th Apr 2024
The Investment Committee give you their top stocks to watch for the second half.
Amgen (AMGN) Laps the Stock Market: Here's Why
07:06pm, Thursday, 11'th Apr 2024
In the most recent trading session, Amgen (AMGN) closed at $270, indicating a +1.33% shift from the previous trading day.
Is Amgen Stock a Buy?
08:00am, Thursday, 11'th Apr 2024
Amgen has been busy with a couple of multi-billion dollar acquisitions over the past few years. While they should create growth opportunities, the drugmaker has also taken on quite a bit of debt.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
02:00pm, Sunday, 07'th Apr 2024
Looking ahead, the future of the U.S. economy appears promising despite ongoing challenges. President Biden's efforts to steer the economy through inflation concerns are showing strong results.